Table 2.

Linear Regression Analysis of Biomarker Level According to LVH Category

Biomarker	Without LVH	With LVH	Ratio	P Value
NT‐proBNP, ng/L	924 (903–946)	1220 (1169–1273)	1.32 (1.26–1.39)	<0.0001
Troponin I, ng/L	7.1 (6.9–7.3)	11.8 (11.2–12.5)	1.67 (1.57–1.78)	<0.0001
Troponin T, ng/L	11.6 (11.4–11.9)	16.2 (15.6–16.9)	1.40 (1.34–1.46)	<0.0001
GDF‐15, ng/L	1589 (1567–1612)	1735 (1690–1780)	1.09 (1.06–1.12)	<0.0001

Data are given as geometric mean (95% CI). Multiple linear regression analyses with log‐transformed continuous biomarker levels as outcome in models including LVH category (no/yes), age, sex, body mass index, current smoking, heart failure, hypertension, prior myocardial infarction, diabetes mellitus, systolic blood pressure, permanent atrial fibrillation, creatinine clearance, digoxin use, and angiotensin‐converting enzyme inhibitor/angiotensin II receptor blocker as explanatory variables. GDF‐15 indicates growth differentiation factor‐15; LVH, left ventricular hypertrophy; NT‐proBNP, N‐terminal pro‐B‐type natriuretic peptide.